Large-scale testing (Phase 3)WithdrawnNCT00874302
What this trial is testing
Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms
Who this might be right for
Uterine Fibroids
Repros Therapeutics Inc.